Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Immune Deficiency”

1,070 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,070 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableStudy completedNCT01524900
What this trial is testing

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Who this might be right for
HIV Infections
Boehringer Ingelheim 398
Testing effectiveness (Phase 2)Study completedNCT00000811
What this trial is testing

Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children

Who this might be right for
Bacterial InfectionsPneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 690
Not applicableStudy completedNCT00000950
What this trial is testing

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT00000674
What this trial is testing

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

Who this might be right for
Toxoplasmosis, CerebralHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Not applicableStudy completedNCT00001990
What this trial is testing

An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT00002122
What this trial is testing

Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

Who this might be right for
MycosesMycobacterium Avium-Intracellulare InfectionHIV Infections
Pfizer 720
Testing effectiveness (Phase 2)Study completedNCT00000851
What this trial is testing

Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 198
Early research (Phase 1)Study completedNCT00000887
What this trial is testing

Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00001993
What this trial is testing

Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3

Who this might be right for
HIV Infections
G D Searle 120
Testing effectiveness (Phase 2)Ended earlyNCT05405309
What this trial is testing

RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
University of Utah 5
Early research (Phase 1)Study completedNCT00001005
What this trial is testing

Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT00460746
What this trial is testing

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Who this might be right for
HIV
Tibotec, Inc 10
Large-scale testing (Phase 3)Study completedNCT03227861
What this trial is testing

Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care

Who this might be right for
HIV-1
Janssen Scientific Affairs, LLC 109
Early research (Phase 1)Study completedNCT00000986
What this trial is testing

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Large-scale testing (Phase 3)Study completedNCT00002070
What this trial is testing

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Schering-Plough
Testing effectiveness (Phase 2)Study completedNCT00001039
What this trial is testing

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT00771498
What this trial is testing

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Who this might be right for
HIV InfectionTuberculosis
Oswaldo Cruz Foundation 30
Not applicableWithdrawnNCT00037063
What this trial is testing

See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Next Page